09/06/2010 

  Annual Reports
  Board of Directors
  Fact Sheet
  Honours and Awards
  Links
  Senior Management Team
  Scientific Publications
  Vision and Priorities














Scientific Publications Database

Article Title: Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection
Authors: Shepard BD;Loutfy MR;Raboud J;Mandy F;Kovacs CM;Diong C;Bergeron M;Govan V;Rizza SA;Angel JB;Badley AD;
Journal: Journal of Acquired Immune Deficiency Syndromes: JAIDS Volume 48 , Issue2
Date of Publication:2008 Jun 1
Abstract:
OBJECTIVE: Because effective antiretroviral therapy (ART) reduces immune activation, we hypothesize that early changes in immune activation are associated with subsequent virologic response to therapy. DESIGN: Observational cohort study. SETTING: Institutional HIV clinic. SUBJECTS: Thirty-four adult HIV patients with virologic failure on their current antiretroviral regimen. INTERVENTION: Change to salvage regimen selected by patient's physician. MAIN OUTCOME MEASURES: Measures of immune activation at baseline and at 2, 4, 8, and 24 weeks after enrollment. Data were analyzed by proportional hazards (PH) models. RESULTS: PH models showed that reductions between baseline and week 2 in expression of CD38 (P = 0.02) or CD95 (P = 0.02) on CD4 T cells were associated with increased likelihood of achieving virologic suppression. Kaplan-Meier analysis demonstrated that patients who had reductions within the first 2 weeks of therapy in CD4 T-cell expression of CD38 (P = 0.003) or CD95 (P = 0.08) were more likely to achieve viral suppression than those who did not. CONCLUSIONS: Reduced CD4 T-cell expression of CD38 and CD95 occurring within 2 weeks of salvage therapy is associated with subsequent viral suppression. Monitoring CD38 and CD95 may allow earlier assessment of the response to ART.

Copyright © 1996-2010, All rights reserved, Ottawa Hospital Research Institute

Clicky Web Analytics